Tech Company Financing Transactions
Xoc Pharmaceuticals Funding Round
Xoc Pharmaceuticals, operating out of Los Gatos, scored $30 million in investment from New Enterprise Associates and private investors.
Transaction Overview
Company Name
Announced On
2/7/2018
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors
New Enterprise Associates (Lead Investor) (Frank Torti)
Proceeds Purpose
The funding will enable us to complete pre-clinical testing and take our two lead compounds into the clinic.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
16615 Lark Ave. 100
Los Gatos, CA 95032
USA
Los Gatos, CA 95032
USA
Phone
Undisclosed
Website
Email Address
Overview
The company's initial area of focus is the development of novel oral therapies for migraine prevention and dopamine agonism for Parkinson's disease management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Borland
Chief Technical Officer
Thomas Armer
VP - Operations
Miguel Guzman
Browse more venture capital transactions:
Prev: 2/7/2018: IntuiLab venture capital transaction
Next: 2/7/2018: Loris.ai venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs